Lenox Wealth Advisors’s GSK GSK Stock Holding History

Lenox Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-62	Closed	-$3K	–	483
2019 Q1	$3K	Buy	+62	New	+$3.1K	﹤0.01%	454
2015 Q4	–	Sell	-114	Closed	-$5K	–	529
2015 Q3	$5K	Hold	114	–	–	﹤0.01%	255
2015 Q2	$6K	Hold	114	–	–	﹤0.01%	193
2015 Q1	$7K	Hold	114	–	–	﹤0.01%	196
2014 Q4	$6K	Hold	114	–	–	﹤0.01%	215
2014 Q3	$7K	Buy	+114	New	+$6.99K	﹤0.01%	202

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Lenox Wealth Advisors's GSK Position: Q2 2019 in Review

Lenox Wealth Advisors sold out of GSK (GSK) in Q2 2019, closing a stake of 62 shares — an estimated $3K sold.

Lenox Wealth Advisors first reported a position in GSK in Q3 2014 and held it in 6 quarters. The position peaked at $7K in Q1 2015. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

Lenox Wealth Advisors reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
Lenox Wealth Advisors sold 62 GSK shares in Q2 2019, an estimated $3K.
Lenox Wealth Advisors first reported a position in GSK in Q3 2014 and held it in 6 quarters.
Lenox Wealth Advisors's GSK position peaked at $7K in Q1 2015.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Lenox Wealth Advisors's 13F filing for Q2 2019, filed 12 Jul 2019.